The use of the optical imaging agent FG001 led to the detection of additional cancer by optical guidance in patients with high-grade glioma, meeting the primary end point of the phase 2b FG001-CT-001 trial.
Related Keywords
Denmark , Copenhagen , Køavn , Andreas Kjaer , Jane Skj , Department Of Neurosurgery At Rigshospitalet , , Fg001 , High Grade Glioma , Phase 2b Fg001 Ct 001 Trial Eudract 2020 003089 38 ,
comparemela.com © 2020. All Rights Reserved.